Compounds > celecoxib

celecoxib and s20098

celecoxib has been researched along with s20098 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Fang, P; He, J; Liu, T; Wang, C; Wen, J; Xu, RA; Zhang, B; Zheng, X1

Other Studies

2 other study(ies) available for celecoxib and s20098

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Inhibitory effect of celecoxib on agomelatine metabolism in vitro and in vivo.
    Drug design, development and therapy, 2018, Volume: 12

    Topics: Acetamides; Administration, Oral; Animals; Celecoxib; Cytochrome P-450 CYP2C9; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Male; Microsomes, Liver; Molecular Structure; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Structure-Activity Relationship

2018